TY - JOUR AU - Masoli, M. a. t. t. h. e. w. AU - Fabian, D. e. n. i. s. e. AU - Holt, S. h. a. u. n. AU - Beasley, R. i. c. h. a. r. d. PY - 2004 DA - 2004// TI - The global burden of asthma: executive summary of the GINA Dissemination Committee Report JO - Allergy VL - 59 UR - https://doi.org/10.1111/j.1398-9995.2004.00526.x DO - 10.1111/j.1398-9995.2004.00526.x ID - Masoli2004 ER - TY - STD TI - Global Strategy for Asthma Management and Prevention, 2017. Available from: http://www.ginasthma/.org. UR - http://www.ginasthma/.org ID - ref2 ER - TY - STD TI - Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the REcognise asthma and LInk to symptoms and experience (REALISE) survey. Npj Primary Care Respiratory Medicine. 2014;24. ID - ref3 ER - TY - JOUR AU - Stead, R. J. AU - Cooke, N. J. PY - 1989 DA - 1989// TI - Adverse effects of inhaled corticosteroids JO - Bmj VL - 298 UR - https://doi.org/10.1136/bmj.298.6671.403 DO - 10.1136/bmj.298.6671.403 ID - Stead1989 ER - TY - JOUR AU - Hirai, H. AU - Tanaka, K. AU - Yoshie, O. AU - Ogawa, K. AU - Kenmotsu, K. AU - Takamori, Y. AU - Ichimasa, M. AU - Sugamura, K. AU - Nakamura, M. AU - Takano, S. AU - Nagata, K. PY - 2001 DA - 2001// TI - Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2 JO - J Exp Med VL - 193 UR - https://doi.org/10.1084/jem.193.2.255 DO - 10.1084/jem.193.2.255 ID - Hirai2001 ER - TY - JOUR AU - Xue, L. AU - Barrow, A. AU - Pettipher, R. PY - 2009 DA - 2009// TI - Novel function of CRTH2 in preventing apoptosis of human Th2 cells through activation of the phosphatidylinositol 3-kinase pathway JO - J Immunol VL - 182 UR - https://doi.org/10.4049/jimmunol.0804090 DO - 10.4049/jimmunol.0804090 ID - Xue2009 ER - TY - JOUR AU - Xue, L. AU - Gyles, S. L. AU - Wettey, F. R. AU - Gazi, L. AU - Townsend, E. AU - Hunter, M. G. AU - Pettipher, R. PY - 2005 DA - 2005// TI - Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells JO - J Immunol VL - 175 UR - https://doi.org/10.4049/jimmunol.175.10.6531 DO - 10.4049/jimmunol.175.10.6531 ID - Xue2005 ER - TY - JOUR AU - Lukacs, N. W. AU - Berlin, A. A. AU - Franz-Bacon, K. AU - Sasik, R. AU - Sprague, L. J. AU - Ly, T. W. AU - Hardiman, G. AU - Boehme, S. A. AU - Bacon, K. B. PY - 2008 DA - 2008// TI - CRTH2 antagonism significantly ameliorates airway hyperreactivity and downregulates inflammation-induced genes in a mouse model of airway inflammation JO - Am J Phys Lung Cell Mol Phys VL - 295 ID - Lukacs2008 ER - TY - JOUR AU - Stebbins, K. J. AU - Broadhead, A. R. AU - Correa, L. D. AU - Scott, J. M. AU - Truong, Y. P. AU - Stearns, B. A. AU - Hutchinson, J. H. AU - Prasit, P. AU - Evans, J. F. AU - Lorrain, D. S. PY - 2010 DA - 2010// TI - Therapeutic efficacy of AM156, a novel prostanoid DP2 receptor antagonist, in murine models of allergic rhinitis and house dust mite-induced pulmonary inflammation JO - Eur J Pharmacol VL - 638 UR - https://doi.org/10.1016/j.ejphar.2010.04.031 DO - 10.1016/j.ejphar.2010.04.031 ID - Stebbins2010 ER - TY - STD TI - Uller L, Mathiesen JM, Alenmyr L, Korsgren M, Ulven T, Hogberg T, Andersson G, Persson CGA, Kostenis E. Antagonism of the prostaglandin D-2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation. Respir Res. 2007;8. ID - ref10 ER - TY - JOUR AU - Barnes, N. AU - Pavord, I. AU - Chuchalin, A. AU - Bell, J. AU - Hunter, M. AU - Lewis, T. AU - Parker, D. AU - Payton, M. AU - Collins, L. P. AU - Pettipher, R. PY - 2012 DA - 2012// TI - A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma JO - Clin Exp Allergy VL - 42 UR - https://doi.org/10.1111/j.1365-2222.2011.03813.x DO - 10.1111/j.1365-2222.2011.03813.x ID - Barnes2012 ER - TY - JOUR AU - Pettipher, R. AU - Hunter, M. G. AU - Perkins, C. M. AU - Collins, L. P. AU - Lewis, T. AU - Baillet, M. AU - Steiner, J. AU - Bell, J. AU - Payton, M. A. PY - 2014 DA - 2014// TI - Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459 JO - Allergy VL - 69 UR - https://doi.org/10.1111/all.12451 DO - 10.1111/all.12451 ID - Pettipher2014 ER - TY - JOUR AU - Singh, D. AU - Cadden, P. AU - Hunter, M. AU - Pearce Collins, L. AU - Perkins, M. AU - Pettipher, R. AU - Townsend, E. AU - Vinall, S. AU - O'Connor, B. PY - 2013 DA - 2013// TI - Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459 JO - Eur Respir J VL - 41 UR - https://doi.org/10.1183/09031936.00092111 DO - 10.1183/09031936.00092111 ID - Singh2013 ER - TY - JOUR AU - Hall, I. P. AU - Fowler, A. V. AU - Gupta, A. AU - Tetzlaff, K. AU - Nivens, M. C. AU - Sarno, M. AU - Finnigan, H. A. AU - Bateman, E. D. AU - Sutherland, E. R. PY - 2015 DA - 2015// TI - Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment JO - Pulm Pharmacol Ther VL - 32 UR - https://doi.org/10.1016/j.pupt.2015.03.003 DO - 10.1016/j.pupt.2015.03.003 ID - Hall2015 ER - TY - STD TI - Higgins J, Green S (2013) Cochrane handbook for systematic reviews of interventions version 5.1. 0, the Cochrane collaboration, 2011. ID - ref15 ER - TY - JOUR AU - Bateman, E. r. i. c. D. AU - Guerreros, A. l. f. r. e. d. o. G. AU - Brockhaus, F. l. o. r. i. a. n. AU - Holzhauer, B. j. รถ. r. n. AU - Pethe, A. b. h. i. j. i. t. AU - Kay, R. i. c. h. a. r. d. A. AU - Townley, R. o. b. e. r. t. G. PY - 2017 DA - 2017// TI - Fevipiprant, an oral prostaglandin DP2receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids JO - European Respiratory Journal VL - 50 UR - https://doi.org/10.1183/13993003.00670-2017 DO - 10.1183/13993003.00670-2017 ID - Bateman2017 ER - TY - JOUR AU - Busse, W. W. AU - Wenzel, S. E. AU - Meltzer, E. O. AU - Kerwin, E. M. AU - Liu, M. C. AU - Zhang, N. AU - Chon, Y. AU - Budelsky, A. L. AU - Lin, J. AU - Lin, S. L. PY - 2013 DA - 2013// TI - Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients JO - J Allergy Clin Immunol VL - 131 UR - https://doi.org/10.1016/j.jaci.2012.10.013 DO - 10.1016/j.jaci.2012.10.013 ID - Busse2013 ER - TY - JOUR AU - Erpenbeck, V. J. AU - Popov, T. A. AU - Miller, D. AU - Weinstein, S. F. AU - Spector, S. AU - Magnusson, B. AU - Osuntokun, W. AU - Goldsmith, P. AU - Weiss, M. AU - Beier, J. PY - 2016 DA - 2016// TI - The oral CRTh2 antagonist QAW039 (fevipiprant): a phase II study in uncontrolled allergic asthma JO - Pulmonary Pharmacology and Therapeutics VL - 39 UR - https://doi.org/10.1016/j.pupt.2016.06.005 DO - 10.1016/j.pupt.2016.06.005 ID - Erpenbeck2016 ER - TY - JOUR AU - Fowler, A. AU - Koenen, R. AU - Hilbert, J. AU - Blatchford, J. AU - Kappeler, D. AU - Benediktus, E. AU - Wood, C. AU - Gupta, A. PY - 2017 DA - 2017// TI - Safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel CRTH2 antagonist BI 1021958 at single Oral doses in healthy men and multiple Oral doses in men and women with well-controlled asthma JO - J Clin Pharmacol VL - 57 UR - https://doi.org/10.1002/jcph.947 DO - 10.1002/jcph.947 ID - Fowler2017 ER - TY - JOUR AU - Gonem, S. AU - Berair, R. AU - Singapuri, A. AU - Hartley, R. AU - Laurencin, M. F. M. AU - Bacher, G. AU - Holzhauer, B. AU - Bourne, M. AU - Mistry, V. AU - Pavord, I. D. PY - 2016 DA - 2016// TI - Fevipiprant, a prostaglandin D-2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-Centre, randomised, double-blind, parallel-group, placebo-controlled trial JO - Lancet Respiratory Medicine VL - 4 UR - https://doi.org/10.1016/S2213-2600(16)30179-5 DO - 10.1016/S2213-2600(16)30179-5 ID - Gonem2016 ER - TY - JOUR AU - Kuna, P. AU - Bjermer, L. AU - Tornling, G. PY - 2016 DA - 2016// TI - Two phase II randomized trials on the CRTh2 antagonist AZD1981 in adults with asthma JO - Drug Design Development and Therapy VL - 10 UR - https://doi.org/10.2147/DDDT.S105142 DO - 10.2147/DDDT.S105142 ID - Kuna2016 ER - TY - JOUR AU - Wenzel, S. a. l. l. y. E. AU - Hopkins, R. o. b. e. r. t. AU - Saunders, M. i. c. h. a. e. l. AU - Chantry, D. a. v. i. d. AU - Anderson, L. i. s. a. AU - Aitchison, R. o. g. e. r. AU - Eberhardt, C. h. r. i. s. t. i. n. e. AU - Bell, S. t. a. c. i. e. AU - Cole, J. e. r. e. m. y. AU - Wolfe, J. a. m. e. s. AU - Spector, S. h. e. l. d. o. n. L. AU - Sher, L. a. w. r. e. n. c. e. D. AU - Kerwin, E. d. w. a. r. d. M. AU - Burgess, L. a. r. r. y. PY - 2014 DA - 2014// TI - Safety and Efficacy Of ARRY-502, a Potent, Selective, Oral CRTh2 Antagonist, In Patients With Mild To Moderate Th2-Driven Asthma JO - Journal of Allergy and Clinical Immunology VL - 133 UR - https://doi.org/10.1016/j.jaci.2013.12.037 DO - 10.1016/j.jaci.2013.12.037 ID - Wenzel2014 ER - TY - JOUR AU - Bateman, E. D. AU - O'Brien, C. AU - Rugman, P. AU - Luke, S. AU - Ivanov, S. AU - Uddin, M. PY - 2018 DA - 2018// TI - Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting beta2-agonists in patients with atopic asthma JO - Drug Design, Development and Therapy VL - 12 UR - https://doi.org/10.2147/DDDT.S147389 DO - 10.2147/DDDT.S147389 ID - Bateman2018 ER - TY - JOUR AU - Diamant, Z. AU - Sidharta, P. N. AU - Singh, D. AU - O'Connor, B. J. AU - Zuiker, R. AU - Leaker, B. R. AU - Silkey, M. AU - Dingemanse, J. PY - 2014 DA - 2014// TI - Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics JO - Clin Exp Allergy VL - 44 UR - https://doi.org/10.1111/cea.12357 DO - 10.1111/cea.12357 ID - Diamant2014 ER - TY - JOUR AU - Miller, D. AU - Wood, C. AU - Bateman, E. AU - LaForce, C. AU - Blatchford, J. AU - Hilbert, J. AU - Gupta, A. AU - Fowler, A. PY - 2017 DA - 2017// TI - A randomized study of BI 671800, a CRTH2 antagonist, as add-on therapy in poorly controlled asthma JO - Allergy and Asthma Proceedings VL - 38 UR - https://doi.org/10.2500/aap.2017.38.4034 DO - 10.2500/aap.2017.38.4034 ID - Miller2017 ER - TY - JOUR AU - Frey, U. AU - Brodbeck, T. AU - Majumdar, A. AU - Taylor, D. R. AU - Town, G. I. AU - Silverman, M. AU - Suki, B. PY - 2005 DA - 2005// TI - Risk of severe asthma episodes predicted from fluctuation analysis of airway function JO - Nature VL - 438 UR - https://doi.org/10.1038/nature04176 DO - 10.1038/nature04176 ID - Frey2005 ER - TY - JOUR AU - O'Byrne, P. M. AU - Inman, M. D. PY - 2003 DA - 2003// TI - Airway hyperresponsiveness JO - Chest VL - 123 UR - https://doi.org/10.1378/chest.123.3_suppl.411S DO - 10.1378/chest.123.3_suppl.411S ID - O'Byrne2003 ER - TY - JOUR AU - Royer, J. F. AU - Schratl, P. AU - Lorenz, S. AU - Kostenis, E. AU - Ulven, T. AU - Schuligoi, R. AU - Peskar, B. A. AU - Heinemann, A. PY - 2007 DA - 2007// TI - A novel antagonist of CRTH2 blocks eosinophil release from bone marrow, chemotaxis and respiratory burst JO - Allergy VL - 62 UR - https://doi.org/10.1111/j.1398-9995.2007.01452.x DO - 10.1111/j.1398-9995.2007.01452.x ID - Royer2007 ER - TY - JOUR AU - Gleich, G. J. PY - 2000 DA - 2000// TI - Mechanisms of eosinophil-associated inflammation JO - J Allergy Clin Immunol VL - 105 UR - https://doi.org/10.1067/mai.2000.105712 DO - 10.1067/mai.2000.105712 ID - Gleich2000 ER - TY - JOUR AU - Larche, M. AU - Robinson, D. S. AU - Kay, A. B. PY - 2003 DA - 2003// TI - The role of T lymphocytes in the pathogenesis of asthma JO - J Allergy Clin Immunol VL - 111 UR - https://doi.org/10.1067/mai.2003.169 DO - 10.1067/mai.2003.169 ID - Larche2003 ER - TY - JOUR AU - Atamas, S. P. AU - Yurovsky, V. V. AU - Wise, R. AU - Wigley, F. M. AU - Goter Robinson, C. J. AU - Henry, P. AU - Alms, W. J. AU - White, B. PY - 1999 DA - 1999// TI - Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis JO - Arthritis Rheum VL - 42 UR - https://doi.org/3.0.CO;2-L DO - 3.0.CO;2-L ID - Atamas1999 ER - TY - JOUR AU - Llewellin, P. AU - Sawyer, G. AU - Lewis, S. AU - Cheng, S. AU - Weatherall, M. AU - Fitzharris, P. AU - Beasley, R. PY - 2002 DA - 2002// TI - The relationship between FEV1 and PEF in the assessment of the severity of airways obstruction JO - Respirology VL - 7 UR - https://doi.org/10.1046/j.1440-1843.2002.00417.x DO - 10.1046/j.1440-1843.2002.00417.x ID - Llewellin2002 ER - TY - JOUR AU - Aggarwal, A. N. AU - Gupta, D. AU - Jindal, S. K. PY - 2006 DA - 2006// TI - The relationship between FEV1 and peak expiratory flow in patients with airways obstruction is poor JO - Chest VL - 130 UR - https://doi.org/10.1016/S0012-3692(15)37323-2 DO - 10.1016/S0012-3692(15)37323-2 ID - Aggarwal2006 ER - TY - JOUR AU - Juniper, E. F. AU - Guyatt, G. H. AU - Epstein, R. S. AU - Ferrie, P. J. AU - Jaeschke, R. AU - Hiller, T. K. PY - 1992 DA - 1992// TI - Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials JO - Thorax VL - 47 UR - https://doi.org/10.1136/thx.47.2.76 DO - 10.1136/thx.47.2.76 ID - Juniper1992 ER - TY - JOUR AU - Juniper, E. F. AU - Svensson, K. AU - Mork, A. C. AU - Stahl, E. PY - 2005 DA - 2005// TI - Measurement properties and interpretation of three shortened versions of the asthma control questionnaire JO - Respir Med VL - 99 UR - https://doi.org/10.1016/j.rmed.2004.10.008 DO - 10.1016/j.rmed.2004.10.008 ID - Juniper2005 ER - TY - JOUR AU - Masoli, M. AU - Fabian, D. AU - Holt, S. AU - Beasley, R. PY - 2004 DA - 2004// TI - The global burden of asthma: executive summary of the GINA dissemination committee report JO - Allergy VL - 59 UR - https://doi.org/10.1111/j.1398-9995.2004.00526.x DO - 10.1111/j.1398-9995.2004.00526.x ID - Masoli2004 ER - TY - JOUR AU - Tran, T. N. AU - Khatry, D. B. AU - Ke, X. AU - Ward, C. K. AU - Gossage, D. PY - 2014 DA - 2014// TI - High blood eosinophil count is associated with more frequent asthma attacks in asthma patients JO - Ann Allergy Asthma Immunol VL - 113 UR - https://doi.org/10.1016/j.anai.2014.04.011 DO - 10.1016/j.anai.2014.04.011 ID - Tran2014 ER - TY - JOUR AU - Simpson, J. L. AU - Scott, R. AU - Boyle, M. J. AU - Gibson, P. G. PY - 2006 DA - 2006// TI - Inflammatory subtypes in asthma: assessment and identification using induced sputum JO - Respirology VL - 11 UR - https://doi.org/10.1111/j.1440-1843.2006.00784.x DO - 10.1111/j.1440-1843.2006.00784.x ID - Simpson2006 ER - TY - JOUR AU - Xue, L. AU - Salimi, M. AU - Panse, I. AU - Mjosberg, J. M. AU - McKenzie, A. N. AU - Spits, H. AU - Klenerman, P. AU - Ogg, G. PY - 2014 DA - 2014// TI - Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells JO - J Allergy Clin Immunol VL - 133 UR - https://doi.org/10.1016/j.jaci.2013.10.056 DO - 10.1016/j.jaci.2013.10.056 ID - Xue2014 ER - TY - JOUR AU - Dweik, R. A. AU - Boggs, P. B. AU - Erzurum, S. C. AU - Irvin, C. G. AU - Leigh, M. W. AU - Lundberg, J. O. AU - Olin, A. C. AU - Plummer, A. L. AU - Taylor, D. R. PY - 2011 DA - 2011// TI - An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications JO - Am J Respir Crit Care Med VL - 184 UR - https://doi.org/10.1164/rccm.9120-11ST DO - 10.1164/rccm.9120-11ST ID - Dweik2011 ER - TY - JOUR AU - Singh, D. AU - Richards, D. AU - Knowles, R. G. AU - Schwartz, S. AU - Woodcock, A. AU - Langley, S. AU - O'Connor, B. J. PY - 2007 DA - 2007// TI - Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma JO - Am J Respir Crit Care Med VL - 176 UR - https://doi.org/10.1164/rccm.200704-588OC DO - 10.1164/rccm.200704-588OC ID - Singh2007 ER - TY - JOUR AU - Juniper, E. F. AU - Guyatt, G. H. AU - Willan, A. AU - Griffith, L. E. PY - 1994 DA - 1994// TI - Determining a minimal important change in a disease-specific quality of life questionnaire JO - J Clin Epidemiol VL - 47 UR - https://doi.org/10.1016/0895-4356(94)90036-1 DO - 10.1016/0895-4356(94)90036-1 ID - Juniper1994 ER - TY - JOUR AU - Reddel, H. K. AU - Taylor, D. R. AU - Bateman, E. D. AU - Boulet, L. P. AU - Boushey, H. A. AU - Busse, W. W. AU - Casale, T. B. AU - Chanez, P. AU - Enright, P. L. AU - Gibson, P. G. PY - 2009 DA - 2009// TI - An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice JO - Am J Respir Crit Care Med VL - 180 UR - https://doi.org/10.1164/rccm.200801-060ST DO - 10.1164/rccm.200801-060ST ID - Reddel2009 ER -